Page last updated: 2024-11-05

trimebutine and Acute Disease

trimebutine has been researched along with Acute Disease in 2 studies

Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.

Acute Disease: Disease having a short and relatively severe course.

Research Excerpts

ExcerptRelevanceReference
"Trimebutine is an opioid derivative with exclusive action on receptors of the Meissner and Auerbach plexus throughout the digestive tube."2.72Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study. ( Bigal, ME; Filho, PF; Krymchantowski, AV, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krymchantowski, AV1
Filho, PF1
Bigal, ME1
Le Blanc-Louvry, I1
Denis, P1
Ducrotte, P1

Trials

1 trial available for trimebutine and Acute Disease

ArticleYear
Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
    Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Drug Combinations; Female; Gastrointestinal Agents; Gastropa

2006

Other Studies

1 other study available for trimebutine and Acute Disease

ArticleYear
The role of remote gut inflammation in duodenojejunal dysmotility.
    Neurogastroenterology and motility, 2002, Volume: 14, Issue:2

    Topics: Acute Disease; Area Under Curve; Chi-Square Distribution; Cholecystitis; Cholelithiasis; Colic; Duod

2002